Skip to content

The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on 24-Hour Ambulatory Blood Pressure in Hypertensive Patients: A Single-Blind, Multicenter, Randomized Controlled Clinical Trial

The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on 24-Hour Ambulatory Blood Pressure in Hypertensive Patients: A Single-Blind, Multicenter, Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119276
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-03-10
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hypertension

Interventions

Intervention Group:Percutaneous ear vagus nerve stimulation

Sponsors

The First Affiliated Hospital of Henan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Male or female patients with hypertension aged between 18 and 70 years. 2. Meet the diagnostic criteria for essential hypertension as specified in Chinese Guidelines for the Prevention and Treatment of Hypertension (Revised Edition 2024). 3. Not taking medication or currently using monotherapy or combination therapy, and the medication regimen cannot be adjusted during the trial period. 4. Voluntarily participate in this study and sign an informed consent form. 5. Able to understand and comply with all requirements during the research process, including treatment, follow-up, and examinations.

Exclusion criteria

Exclusion criteria: 1. Confirmed secondary hypertension (such as renal vascular hypertension, primary aldosteronism, and other hypertension with clear causes). 2. Combined with serious heart diseases (such as acute myocardial infarction, heart failure, severe arrhythmia, etc.), cerebrovascular diseases (such as acute stroke, frequent transient ischemic attacks, etc.), liver and kidney dysfunction, malignant tumors, and other serious systemic diseases. 3. Having mental or cognitive impairments, unable to cooperate with research or understand the content of informed consent forms. 4. Having a history of ear disease or ear surgery may affect the implementation or safety of percutaneous vagus nerve stimulation therapy. 5. Pregnant or lactating women. 6. Other researchers believe that participants who are not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
24-hour average systolic/diastolic blood pressure, average heart rate, daytime average systolic/diastolic blood pressure, nighttime average systolic/diastolic blood pressure;Circadian blood pressure decline rate?Change in blood pressure load value?Change in morning blood pressure peak?24-hour, daytime/nighttime blood pressure standard deviation;

Secondary

MeasureTime frame
Emotional indicators;Sleep quality;

Countries

China

Contacts

Public ContactXiaohong Kang/Chen Zhigang

The First Affiliated Hospital of Henan Medical University

kxhhgd@163.com+86 373 4402895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026